Where Margin Goes When Everything Becomes Commodity
GPU costs dropped 63%, but AWS still charges 171% markup. Frontier models beat specialized AI by 18 points. SaaS sector dropped 40%, but Salesforce grew 169%. Capability became free. Integration became everything.

Spheron will rent you an H100 GPU for $2.54 per hour. AWS charges $6.88 for the exact same chip. That's a 171% markup, or $4.34 extra every single hour.
You might think this price gap creates an obvious arbitrage opportunity. Enterprises see the cheaper option, migrate their AI workloads to Spheron, and AWS loses billions in revenue. The commodity GPU market kills the hyperscaler margin.
Except that's not happening. AWS's cloud margins are perfectly safe. Not because enterprises don't know about the cheaper option (they do), and not because moving is technically impossible (it's straightforward). AWS's $4.34 markup isn't for the GPU. It's for compliance frameworks worth $1.50 to $2.00 per hour, ecosystem integration worth $0.60 to $1.00 per hour, and switching costs worth $1.50 to $2.50 per hour. Spheron can't compete on any of those layers because offering them requires years of enterprise relationships, regulatory certifications, and a software ecosystem that took a decade to build.
Meanwhile, something stranger is happening in the application layer. A Nature Medicine study published June 23 found that GPT-5.2 (a general-purpose frontier model anyone can access) scored 91.2% accuracy on medical diagnosis questions. OpenEvidence, a specialized AI model built specifically for medical use and trained on years of clinical data, scored 84.1%. The frontier model beat the specialist by 7 percentage points. On clinical approval ratings, the gap widened to 18 points: 89.3% versus 71.4%.
This is the opposite of how markets usually work. Specialists are supposed to win. A cardiologist beats a general practitioner at diagnosing heart conditions. A tax attorney beats a general lawyer at tax law. But in AI, the thing trained on everything is beating the thing trained on one domain. Capability (the actual intelligence of the model, the accuracy of the diagnosis, the quality of the output) is becoming free. You don't need to build a specialized medical AI anymore. You can just use GPT-5.2, which costs a fraction as much to develop and run.
So if capability is free, and infrastructure is commodity, where does margin actually live? This is the question every investor, strategist, and builder needs to answer, because the companies betting on the wrong answer are losing immediately.
TL;DR — Capability (models, algorithms, hardware) became commodity. Margin migrated to integration, compliance, and governance. Frontier models beat specialized AI by 7 to 18 points, killing the specialist moat. GPU pricing dropped 63%, but hyperscalers still charge 171% markups because they're not selling hardware, they're selling lock-in. SaaS sector repriced down 40%, but companies executing fast on outcome-based pricing (Salesforce at 169% growth, HubSpot hitting 2027 targets early) are re-rating upward. The pattern repeats everywhere: vendors selling capability die, vendors selling integration survive. The blog explains exactly where margin lives now, why three seemingly contradictory valuation trends are all correct, and which moats last versus which expire in 18 months.
In this piece:
- AWS charges 171% markup over commodity GPU providers, and the markup is completely defensible because enterprises pay for compliance and switching costs, not hardware.
- Frontier models like GPT-5.2 beat specialized medical AI by 7 to 18 percentage points, which means building domain-specific models no longer creates a moat.
- SaaS sector dropped 40% on per-seat pricing collapse, but Salesforce and HubSpot executing repricing fast are growing at 169% and hitting margin targets early, proving execution speed matters more than sector trends.
- Labs hitting $1 billion ARR stay independent via partnerships (Anthropic with Amazon's $33 billion guarantee), while labs that can't scale get acquired at 40x revenue (Mistral at $16 billion).
- Baseten raised $1.5 billion at 1,900% growth by letting enterprises escape cloud lock-in, but that moat expires in 2 to 3 years when AWS builds competing abstraction products.
The GPU That Costs Nothing and Everything
Let's start with the hardware, because it's the clearest example of where margin went.
An H100 GPU is Nvidia's flagship chip for running AI models. It's the same physical chip whether you rent it from Spheron (a decentralized cloud provider) or from AWS. Same transistors, same memory bandwidth, same processing power. Spheron charges $2.54 per hour. AWS charges $6.88 per hour.
The $4.34 difference isn't markup on the chip. AWS isn't paying $2.54 and pocketing $4.34 in profit. That $4.34 is the price of three things Spheron can't offer:
Compliance costs about $1.50 to $2.00 per hour. If you're a bank, hospital, or government contractor, you can't just run your AI workload anywhere. You need SOC 2 Type II certification (an audit proving you handle data securely), HIPAA compliance (for health data), FedRAMP authorization (for federal agencies), and often dozens of other regulatory checkboxes. AWS spent years and hundreds of millions of dollars earning those certifications. Spheron hasn't, and likely won't, because the audit costs are only worth it if you're serving thousands of enterprise customers who need them.
Ecosystem integration costs about $0.60 to $1.00 per hour. Your AI model probably doesn't run in isolation. It pulls data from your company's database, sends results to your CRM, logs metrics to your monitoring dashboard, triggers alerts in Slack, and writes outputs to cloud storage. If all those systems are already on AWS (your database is RDS, your storage is S3, your monitoring is CloudWatch), moving the AI workload to Spheron means connecting an external provider to your internal AWS network. That creates latency (the time it takes for data to move between systems), security risks (now you have an outside vendor accessing your internal data), and integration headaches (you need custom code to connect Spheron's APIs to AWS's APIs). Most companies decide the $4.34 per hour is cheaper than the engineering time required to manage that complexity.
Switching costs are about $1.50 to $2.50 per hour. This is the hardest cost to see, but it's often the largest. Once you've built your AI infrastructure on AWS, your code is written using AWS-specific tools. Your engineers know AWS's interface. Your security team has audited AWS's setup. Your procurement team has a contract with AWS. Moving to Spheron means rewriting code, retraining engineers, re-auditing security, and renegotiating contracts. For a large company running thousands of AI workloads, that switching cost can easily be tens of millions of dollars. Paying an extra $4.34 per hour indefinitely is cheaper than paying $30 million once to switch.
The pattern here is critical: capability became commodity, but integration stayed expensive. Spheron offers the exact same GPU at 63% lower cost. But the GPU is only 37% of what AWS is selling. The other 63% is compliance, ecosystem, and lock-in. And unlike GPUs (which anyone can buy from Nvidia and resell), those three things take years to build and can't be commoditized by a new entrant offering lower prices.
This is why AWS's margins are safe even as GPU pricing collapses. They're not in the GPU business anymore. They're in the integration business.
When the Specialist Loses to the Generalist
Now let's look at what happened to specialized AI, because it's the same pattern playing out one layer up.
For years, the conventional wisdom was that frontier models (the big general-purpose AIs like GPT or Claude) would be good at everything but great at nothing. If you wanted an AI to diagnose medical conditions, you'd train a specialized model on medical textbooks, journal articles, and clinical case files. That specialist model would beat the generalist because it was purpose-built.
The Nature Medicine study in June 2026 tested that assumption. Researchers gave both GPT-5.2 (OpenAI's latest frontier model) and OpenEvidence (a specialized medical AI) the same set of diagnosis questions from MedQA, a standard medical exam.
GPT-5.2 scored 91.2%. OpenEvidence scored 84.1%. The generalist won by 7 percentage points.
Then they tested clinical approval, asking doctors whether they'd trust each AI's recommendations. GPT-5.2 got 89.3% approval. OpenEvidence got 71.4%. The gap widened to 18 percentage points.
This is not supposed to happen. Specialists exist because focus creates advantage. But in AI, scale seems to create more advantage than focus. GPT-5.2 was trained on vastly more data (everything on the internet, not just medical texts), which means it has more context for every question. It's seen medical information, but also psychology research, sociology studies, public health data, and patient forums. That breadth makes it better at diagnosis than a model trained only on clinical data, because real diagnosis requires understanding human behavior and social context, not just memorizing symptoms.
For companies that built specialized AI models, this is devastating. If you spent three years and $50 million building a legal AI, or a finance AI, or a customer service AI, and then GPT-5.2 beats it out of the box, your moat just evaporated. Capability, which you thought was defensible because it required domain expertise and proprietary training data, became commodity the moment frontier models got good enough.
The companies that understood this pivoted. Harvey, a legal AI startup, stopped competing on model quality. They started building agent orchestration (software that coordinates multiple AI models and connects them to legal databases, document systems, and workflow tools). They're not selling capability anymore. They're selling integration. Sound familiar?
Aside: Why did frontier models get so good at specialized tasks? The answer is scale plus reinforcement learning from human feedback (RLHF). GPT-5.2 was trained on trillions of tokens (a token is roughly 4 characters or 0.75 words, the unit AI models process). That means it's seen medical cases, legal briefs, financial reports, and customer service transcripts millions of times. Then OpenAI used RLHF, where humans rate the model's answers and the model learns which types of responses humans prefer. That combination (massive data plus human feedback) made generalist models better at specialized tasks than models trained only on specialist data. The specialist never saw enough examples. The generalist saw everything.
The SaaS Repricing That Looks Like Three Different Markets
Now we get to the confusing part, because three things are happening simultaneously in software, and they seem to contradict each other.
First, the SaaS sector dropped 40%. Per-seat pricing (charging companies based on how many employees use the software) is collapsing because AI agents don't need seats. If you used to pay Salesforce $150 per month for 100 sales reps, but now one AI agent does the work of 20 reps, you only need 5 human seats. Salesforce's revenue from your company just dropped 95%. Investors looked at this math and repriced every SaaS company downward by an average of 40%.
Second, companies executing repricing fast are growing. Salesforce's Agentforce product (which uses AI agents and charges based on outcomes, not seats) hit $800 million in annual recurring revenue with 169% year-over-year growth. HubSpot, another big SaaS company, shifted to outcome-based pricing and hit its 2027 margin targets a year early. These companies are re-rating upward, even as the sector overall dropped 40%.
Third, specialized AI vendors are surviving longer than expected. The conventional wisdom after the frontier-model-beats-specialist result was that all specialized AI companies would die within 12 months. But that's not happening. Companies with regulatory moats (special certifications or licenses required to operate in their industry), data moats (proprietary datasets that frontier models can't access), or governance moats (systems for auditing and controlling AI decisions that enterprises require) are getting a 3 to 5 year reprieve. They're pivoting from selling capability to selling compliance, exactly like AWS did with GPUs.
So which is it? Is SaaS dying, thriving, or bifurcating?
The answer is all three, but on different timelines.
The SaaS sector dropped 40% because the market priced in a slow 12 to 18 month repricing cycle. Most SaaS companies are still on per-seat contracts that won't expire until 2027 or 2028. Investors assume that when those contracts renew, companies will renegotiate to outcome-based pricing or switch to cheaper AI-native alternatives. That assumption caused the 40% sector-wide drop.
Companies executing repricing fast are re-rating upward because they're proving the repricing window is shorter than expected. Salesforce and HubSpot didn't wait for contracts to expire. They launched agent-based products now, gave existing customers incentives to switch early, and locked in outcome-based pricing before competitors could. The market is rewarding that speed with 10% to 20% valuation increases, even as the sector overall is down 40%. Execution speed became the new moat.
Specialized AI vendors with governance moats get 3 to 5 years because regulation moves slower than technology. Even if GPT-5.2 is better at medical diagnosis than OpenEvidence, hospitals can't just plug in GPT-5.2 and start using it. They need audit trails (records proving every diagnosis decision was made correctly), explainability (the ability to show a doctor exactly why the AI made a recommendation), and liability frameworks (legal agreements specifying who is responsible if the AI makes a mistake). Building those governance layers takes years. Specialized AI vendors that pivoted to building governance infrastructure instead of better models bought themselves a 3 to 5 year window.
The three timelines are: (1) SaaS consolidation takes 12 to 18 months, which is why the sector dropped 40%. (2) Infrastructure moats (AWS's compliance and ecosystem) last 3 to 5 years, which is why hyperscaler margins are safe. (3) Abstraction layers (like Baseten's multi-cloud router) last 2 to 3 years before hyperscalers build competing products, which is why Baseten can raise $1.5 billion now but needs to lock in customers fast.
All three are correct. They're just pricing different expiration dates.
The Lab That Stays Independent and the Lab That Gets Acquired
This same margin-migration pattern explains what happened to AI labs (companies building foundation models like GPT, Claude, or Llama) this year.
Anthropic, the company that makes Claude, announced a partnership with Amazon in April 2026. Amazon committed to a $33 billion capacity guarantee, meaning they'll provide Anthropic with $33 billion worth of compute (server time, GPUs, and infrastructure) over the next few years. In exchange, Anthropic makes Claude available on Amazon's cloud and integrates tightly with Amazon's enterprise tools. Anthropic stays independent. They're not owned by Amazon. They're partnered.
Mistral, a European AI lab, got acquired by a consortium of investors and tech companies in July 2026 for $16 billion. That's about 40 times their annual recurring revenue (meaning if Mistral was making $400 million per year, the acquisition valued them at $16 billion). The reason for the acquisition: Mistral couldn't hit $1 billion ARR fast enough to justify staying independent, so they sold while their valuation was still high.
The dividing line is $1 billion ARR. If you hit $1 billion in annual recurring revenue before you run out of capital or hit a scaling wall, you can stay independent by signing partnership deals (like Anthropic with Amazon). Partnerships give you the infrastructure and distribution you need without giving up ownership. If you can't hit $1 billion ARR, you get acquired, because investors and buyers both know you'll need more capital than you can raise, and consolidation is inevitable.
Why $1 billion? Because that's roughly the revenue threshold where you can afford to build your own infrastructure and sign enterprise partnerships without needing a hyperscaler to subsidize you. Below $1 billion, you're dependent on someone else's infrastructure, which means you're either a feature or an acquisition target.
Notice the pattern again: capability (the quality of the model) doesn't determine who stays independent. Scale and integration do. Mistral's models were competitive with Claude. But Anthropic had Amazon's $33 billion guarantee, and Mistral didn't, so Anthropic stayed independent and Mistral got acquired.
The Abstraction Layer with an Expiration Date
The last piece of the puzzle is Baseten, which raised $1.5 billion in a Series F round in June 2026. Baseten builds multi-cloud abstraction (software that lets you run AI workloads across multiple cloud providers, like AWS, Google Cloud, and Azure, without rewriting code for each one). They grew revenue 1,900% year over year, which is why investors valued them at $1.5 billion.
Here's why that matters: Baseten exists because enterprises want optionality. If you build your entire AI infrastructure on AWS, you're locked into AWS's pricing, and AWS knows it. If you build on Baseten, you can run the same workload on AWS today, Google Cloud tomorrow, and Azure next week, whichever one offers the best price. That optionality saves enterprises millions of dollars and prevents lock-in.
But Baseten's moat has a timer on it. In 2 to 3 years, AWS and Azure will build their own multi-cloud routing tools. They'll offer the same abstraction Baseten provides, bundled into their existing cloud services. When that happens, enterprises will use AWS's abstraction tool instead of paying Baseten, because it's easier to use one vendor than two.
Baseten's founders understand this, which is why they're raising $1.5 billion now and spending it to lock in as many enterprise customers as possible before the window closes. The bet is that if they can get 500 large companies using Baseten deeply (integrated into their core infrastructure, with custom configurations and multi-year contracts), those customers won't switch to AWS's tool even when it's available, because the switching cost will be too high. Baseten is racing to turn a 2-year moat into a 10-year moat by building switching costs before AWS commoditizes the capability.
Sound familiar? Capability (the technical ability to route workloads across clouds) will become commodity in 2 to 3 years. But integration (being deeply embedded in a customer's infrastructure with high switching costs) can last a decade. Baseten is trying to migrate from the first moat to the second before the first one expires.
Where Margin Actually Lives Now
So here's the pattern across all six examples:
- AWS charges 171% markup on GPUs because compliance, ecosystem, and switching costs are worth $4.34 per hour, even though the GPU itself is commodity.
- Frontier models beat specialized AI by 18 points, killing the capability moat for specialized vendors.
- Salesforce and HubSpot survive the 40% SaaS repricing by executing outcome-based pricing fast, which creates new lock-in before per-seat revenue collapses.
- Anthropic stays independent with Amazon's $33 billion partnership, while Mistral gets acquired because they couldn't hit $1 billion ARR.
- Baseten raises $1.5 billion to build switching costs before AWS commoditizes multi-cloud routing in 2 to 3 years.
- Harvey pivots from legal AI capability to agent orchestration and workflow integration.
Margin migrated from capability (models, chips, algorithms, specialist knowledge) to integration (compliance frameworks, ecosystem lock-in, switching costs, governance infrastructure, workflow embedding).
Vendors selling capability are dying. Vendors selling integration are surviving. And vendors that pivot from capability to integration fast enough (Harvey, Salesforce, specialized AI companies with governance moats) buy themselves 3 to 5 extra years.
The question for every strategist, investor, and builder is: are you selling capability or integration? If you're selling capability, you have 12 to 18 months to pivot before you're commodity. If you're selling integration, you have 3 to 5 years before someone figures out how to commoditize your layer. And if you're selling integration but don't have switching costs yet (like Baseten), you're in a race to build them before your window closes.
Margin didn't disappear. It migrated. The winners are the ones who saw it moving and got there first.
Sources & Further Reading
GPU pricing and infrastructure:
- Spheron GPU pricing data (July 2026): spheron.network
- CloudZero GPU pricing comparison (2026): cloudzero.com
- AWS and Azure pricing pages (verified April-June 2026)
- Google Cloud backlog ($460B Q1 2026): Google investor relations
- Meta AI infrastructure spending ($115-135B capex): CNBC, April 2026
Frontier models vs. specialized AI:
- Nature Medicine study (June 23, 2026): "General-purpose large language models outperform specialized clinical AI tools on medical benchmarks," Krithik Vishwanath et al.
- GPT-5.2, Gemini 3.1 Pro, Claude Opus 4.6 performance data: Nature Medicine supplementary materials
- Harvey pivot to agent orchestration: Law.com, June 18, 2026
- Brown University AI cheating case: El País, June 28, 2026
SaaS repricing and outcome-based pricing:
- Salesforce Agentforce: $800M ARR, 169% YoY growth (investor.salesforce.com, Q4 FY26)
- HubSpot Q1 2026 earnings: $881M revenue, 23% YoY growth, margin targets hit early (TIKR, Investing.com)
- Kyle Poyar's 2026 State of B2B Monetization survey: userpilot.com/blog/saas-pricing-models
- Gartner forecasts on outcome-based pricing: softwareseni.com, RSM reports
AI labs, fintech, and consolidation:
- Amazon-Anthropic partnership: $33B capacity guarantee (Forbes, April 2026)
- Mistral acquisition: $16B transaction (TechCrunch, April 2026)
- Kreditbee profitability: INR 478Cr FY26 (~$57M USD) (fintech.global, YourStory)
- Fibe IPO filing: INR 114Cr profit FY26 (Inc42, NDTV Profit, June 2026)
- CRED-Meta investment: $900M Series H (CNBC, Reuters, June 2026)
Multi-cloud abstraction and Baseten:
- Baseten Series F: $1.5B at $13B valuation (VentureBeat, Crunchbase, June 22, 2026)
- Baseten revenue growth: $200M to $600M ARR in one quarter (Sacra, Startup Fortune)
- EU DMA gatekeeper designation for AWS and Azure (June 25, 2026): EU Commission official announcement
Industry analysis and frameworks:
- BetterCloud SaaS industry report 2026: bettercloud.com/monitor/saas-industry
- Futurum AI infrastructure capex research ($690B in 2026): futurumgroup.com
- IEA power grid constraints analysis: enkiai.com, IEA reports